Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex322_6.htm |
| EX-32.1 - EX-32.1 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex321_7.htm |
| EX-31.2 - EX-31.2 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex312_8.htm |
| EX-31.1 - EX-31.1 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex311_9.htm |
| EX-21.1 - EX-21.1 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex211_654.htm |
| EX-10.13 - EX-10.13 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex1013_883.htm |
| EX-10.11 - EX-10.11 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex1011_1078.htm |
| EX-10.10 - EX-10.10 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex1010_1367.htm |
| EX-10.9 - EX-10.9 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex109_1079.htm |
| EX-10.8 - EX-10.8 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex108_1080.htm |
| EX-10.7 - EX-10.7 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex107_1081.htm |
| EX-10.6 - EX-10.6 - LA JOLLA PHARMACEUTICAL CO | ljpc-ex106_2214.htm |
| 10-K - 10-K - LA JOLLA PHARMACEUTICAL CO | ljpc-10k_20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
La Jolla Pharmaceutical Company
San Diego, CA
We consent to the incorporation by reference in Registration Statements (No. 333-214721), (No. 333-221198) and (333-227818) on Form S-3 and (No. 333-184909), (No. 333-193016), (No. 333-207212), (No. 333-214722), (No. 333-221197) and (No. 333-227819) on Form S-8 of La Jolla Pharmaceutical Company of our report dated March 8, 2021 relating to the consolidated financial statements of La Jolla Pharmaceutical Company appearing in this Annual Report on Form 10-K of La Jolla Pharmaceutical Company for the year ended December 31, 2020.
/s/ BAKER TILLY US, LLP
March 8, 2021
San Diego, California